TRACON PHARMACEUTICALS

tracon-pharmaceuticals-logo

TRACON develops targeted therapies for cancer utilizing a capital efficient, CRO independent, product development platform. The Companyโ€™s clinical-stage pipeline includes: Envafolimab, a PD-L1 single-domain antibody given by rapid subcutaneous injection that is being studied in the pivotal ENVASARC trial for sarcoma; TRC102, a Phase 2 small molecule drug candidate for the treatment of lung cancer; and TJ004309, a CD73 antibody in Phase 1 development for the treatment of advanced solid tumors. ... TRACON is actively seeking additional corporate partnerships whereby it leads U.S. regulatory and clinical development, shares in the cost and risk of clinical development, and leads U.S. commercialization. In these partnerships TRACON believes it can serve as a solution for companies without clinical and commercial capabilities in the United States.

#SimilarOrganizations #People #Financial #Event #Website #More

TRACON PHARMACEUTICALS

Social Links:

Industry:
Biotechnology Health Care Medical Device

Founded:
2006-01-01

Address:
San Diego, California, United States

Country:
United States

Website Url:
http://www.traconpharma.com

Total Employee:
11+

Status:
Active

Contact:
(858) 550-0780

Email Addresses:
[email protected]

Total Funding:
113.04 M USD

Technology used in webpage:
Amazon Mobile Non Scaleable Content IPv6 Nginx Google Google Cloud U.S. Server Location Pound Sterling Amazon Virginia Region Microsoft


Similar Organizations

asklepios-biopharmaceutical-logo

Asklepios BioPharmaceutical

Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.

anchiano-therapeutics-logo

Anchiano Therapeutics

Anchiano is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat cancer.

celator-pharmaceuticals-logo

Celator Pharmaceuticals

Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.

cytokinetics-logo

Cytokinetics

Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.

sesen-bio-inc-logo

Sesen Bio, Inc.

Sesen Bio, Inc. is focused on developing innovative protein-based therapeutics to improve human health and treat diseases.

emmaus-medical-logo

Emmaus Medical

Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.

mast-therapeutics-logo

Mast Therapeutics

Mast Therapeutics is a biopharmaceutical company developing novel, clinical-stage therapies for serious or life-threatening diseases.

novabay-pharmaceuticals-logo

NovaBay Pharmaceuticals

NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.

iveric-bio-logo

IVERIC bio

IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.

reata-pharmaceuticals-logo

Reata Pharmaceuticals

Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.


Current Advisors List

lisa-johnson-pratt_image

Lisa Johnson-Pratt Board Member @ TRACON Pharmaceuticals
Board_member
2021-03-01

not_available_image

Kenji Harada Board of Director @ TRACON Pharmaceuticals
Board_member

Current Employees Featured

not_available_image

Scott Brown
Scott Brown Chief Accounting Officer and Head of Finance @ TRACON Pharmaceuticals
Chief Accounting Officer and Head of Finance

not_available_image

Bonne Adams
Bonne Adams EVP Clinical Operations @ TRACON Pharmaceuticals
EVP Clinical Operations
2019-01-01

charles-p-theuer_image

Charles P. Theuer
Charles P. Theuer President and CEO @ TRACON Pharmaceuticals
President and CEO
2006-07-01

not_available_image

Mark Wiggins
Mark Wiggins Chief Business Officer @ TRACON Pharmaceuticals
Chief Business Officer

Founder


charles-p-theuer_image

Charles P. Theuer

Stock Details


Company's stock symbol is NASDAQ:TCON

Investors List

runway-growth-capital_image

Runway Growth Capital

Runway Growth Capital investment in Post-IPO Debt - TRACON Pharmaceuticals

johnson-johnson-innovation_image

Johnson & Johnson Robotics and Digital Solutions

Johnson & Johnson Robotics and Digital Solutions investment in Post-IPO Equity - TRACON Pharmaceuticals

biotech-healthcare-partners_image

Biotech Healthcare Partners

Biotech Healthcare Partners investment in Series B - TRACON Pharmaceuticals

brookline-venture-partners_image

Brookline Venture Partners

Brookline Venture Partners investment in Series B - TRACON Pharmaceuticals

venture-capital_image

Arcus Ventures

Arcus Ventures investment in Series B - TRACON Pharmaceuticals

sahsen-ventures_image

Sahsen Ventures

Sahsen Ventures investment in Series B - TRACON Pharmaceuticals

new-enterprise-associates_image

New Enterprise Associates

New Enterprise Associates investment in Series B - TRACON Pharmaceuticals

nextech-invest_image

Nextech Invest

Nextech Invest investment in Series B - TRACON Pharmaceuticals

biomed-ventures_image

BioMed Ventures

BioMed Ventures investment in Series B - TRACON Pharmaceuticals

jafco-co-ltd_image

JAFCO

JAFCO investment in Series B - TRACON Pharmaceuticals

Newest Events participated

oncology-strategy-meeting-us-west-coast-2018_event_image Participated in Oncology Strategy Meeting US West Coast 2018 on 2018-05-14 as speaker

Official Site Inspections

http://www.traconpharma.com Semrush global rank: 8.27 M Semrush visits lastest month: 590

  • Host name: 209.182.196.37
  • IP address: 209.182.196.37
  • Location: Los Angeles United States
  • Latitude: 33.956
  • Longitude: -118.3887
  • Metro Code: 803
  • Timezone: America/Los_Angeles
  • Postal: 90045

Loading ...

More informations about "TRACON Pharmaceuticals"

TRACON Pharmaceuticals, Inc.

Thank you for visiting the website for TRACON Pharmaceuticals, Inc. ("Company"), a biopharmaceutical company formerly based in San Diego, CA. On November 12, 2024, the Company's stockholders have voted in favor of the โ€ฆSee details»

TRACON Pharmaceuticals | LinkedIn

TRACON is a biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, and utilizes its cost efficient, contract research organization ...See details»

TRACON Pharmaceuticals - Crunchbase Company Profile & Funding

Organization. TRACON Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email โ€ฆSee details»

Tracon Pharmaceuticals Inc (TCON) Profile - The Globe and Mail

Mar 24, 2012 See the company profile for Tracon Pharmaceuticals Inc (TCON) including business summary, industry/sector information, business summary, corporate governance, โ€ฆSee details»

TRACON Pharmaceuticals: Contact Details and Business Profile

TRACON is a biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, and utilizes its cost efficient, contract research โ€ฆSee details»

TRACON Pharmaceuticals, Inc. (TCON) - Yahoo Finance Canada

See the company profile for TRACON Pharmaceuticals, Inc. (TCON) including business summary, industry/sector information, number of employees, business summary, corporate โ€ฆSee details»

TRACON Pharma - Overview, News & Similar companies - ZoomInfo

May 19, 2024 TRACON to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024 SAN DIEGO, May 07, 2024 (GLOBE NEWSWIRE) -- TRACON โ€ฆSee details»

Tracon Pharmaceuticals Inc., Targeted Therapy Cancer, CEO โ€ฆ

[email protected]. Investor Contact: Andrew McDonald, LifeSci Advisors LLC 646-597-6987 ... they outsource the conduct of clinical trials to a contract research organization, or โ€ฆSee details»

TRACON Pharmaceuticals - PitchBook

TRACON Pharmaceuticals General Information Description. TRACON Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer โ€ฆSee details»

TRACON Pharmaceuticals - Craft

Oct 29, 2024 TRACON Pharmaceuticals has 4 employees at their 1 location and $12.05 m in annual revenue in FY 2023. See insights on TRACON Pharmaceuticals including office โ€ฆSee details»

TRACON Pharmaceuticals Company Description - Stock Analysis

Dec 3, 2024 4350 La Jolla Village Drive San Diego, Delaware 92122 United StatesSee details»

Tracon Pharmaceuticals, Inc. Company Profile -Sales, Contacts ...

Tracon Pharmaceuticals, Inc. (trade name Tracon Pharma) is in the Biotechnical Research, Commercial business. View competitors, revenue, employees, website and phone number.See details»

TRACON Pharmaceuticals, Inc. - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for TRACON Pharmaceuticals, Inc. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»

TRACON Pharmaceuticals Overview | SignalHire Company Profile

TRACON Pharmaceuticals is a public company that has been in the industry for 19 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the โ€ฆSee details»

TRACON Pharmaceuticals Company Overview, Contact Details

Traconpharma hired Ya Huang as Executive Director of Statistical Programming on Jun 30th '21. TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company โ€ฆSee details»

TRACON Pharmaceuticals Company Profile: Overview and Full โ€ฆ

TRACON Pharmaceuticals, based in California, is a clinical stage biopharmaceutical company dedicated to developing and commercializing innovative targeted therapies for cancer and โ€ฆSee details»

TRACON Pharmaceuticals CEO and Key Executive Team - Craft

TRACON Pharmaceuticals's President and CEO is Charles P. Theuer. Other executives include Mark Wiggins, Chief Business Officer; Bonne Adams, Executive Vice President and 3 others. โ€ฆSee details»

Working at TRACON Pharmaceuticals - Zippia

Www.traconpharma.com. Organization Type. Public. CEO. Charles P. Theuer. Social Media. TRACON Pharmaceuticals, Inc., a biopharmaceutical company, develops, licenses, and โ€ฆSee details»

TRACON Pharmaceuticals Completes $27 Million Financing and โ€ฆ

San Diego, CA โ€“ September 22, 2014 โ€“ TRACON Pharmaceuticals, a clinical stage biopharmaceutical company focused on the development and commercialization of novel โ€ฆSee details»

TRACON Pharmaceuticals, Inc. (TRACON Pharmaceuticals, Inc.)

ไบ†่งฃTRACON Pharmaceuticals, Inc. (TRACON Pharmaceuticals, Inc.)ๅ…ฌๅธ็š„่ฏ็‰ฉ็ฎก็บฟ๏ผŒๆฒป็–—้ข†ๅŸŸ๏ผŒๆŠ€ๆœฏๅนณๅฐ๏ผŒไปฅๅŠๅฎƒ็š„22้กนไธดๅบŠ่ฏ•้ชŒ, 93็ฏ‡ๆ–ฐ้—ปๅ’Œ29็ฏ‡ๆ–‡็Œฎ๏ผŒ็–พ็—…้ข†ๅŸŸ:่‚ฟ็˜ค๏ผŒ่ก€ๆถฒๅŠๆท‹ๅทด็ณป็ปŸ โ€ฆSee details»

linkstock.net © 2022. All rights reserved